HIGHLIGHTS
- who: Prostate Cancer et al. from the Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China have published the article: Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer, in the Journal: Computational and Mathematical Methods in Medicine 1.00 Progression free survival probability of 20/06/2022
- what: The results of this study show that NRF2 is downregulated in untreated PCa samples compared to normal PCa samples; however it was upregulated in mCRPC samples compared to HSPC samples. The authors propose . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.